Coronavirus – Kenya: COVID-19 update (March 27, 2021)

1,152 people have tested positive for the disease out of a sample size of 8,397. A total of 129,330 positive cases have now been confirmed and the cumulative tests performed so far total 1,463,458.

Nairobi has 458 cases, Nakuru 139, Kiambu 93, Machakos 50, Kajiado 48, Mombasa 47, Turkana 43, Kisumu 27, Garissa 22, Kericho 22, Kilifi 21, Bungoma 20, Laikipia 18, Nyandarua 16, Tharaka Nithi 16, Kitui 13 , Siaya 13, Nyamira 12, Meru 12, Narok 11, Uasin Gishu 8, Bomet 8, Busia 6, Taita Taveta 6, Nyeri 5, Kakamega 5, Kisii 4, Makueni 2, Murang’a 2, Mandera 1, Samburu 1, West Pokot 1, Homa Bay 1 and Isiolo 1.

152 patients have recovered from the disease. 59 are from Home Based and Isolation Care, and 93 are from various health care facilities. The total recovery is now 91,665.

6 deaths have been reported, all of which are late death reports from facility record audits conducted on different dates. This brings our cumulative deaths to 2,104.

A total of 1,212 patients are admitted to various healthcare facilities across the country, while 3,885 patients are isolated and cared for at home. 124 patients are in the Intensive care unit32 of them receive ventilation support and 85 additional oxygen. 7 patients are observed.

Another 86 patients receive additional oxygen separately, 76 of them in the general wards and 10 in the High Dependency Unit (HDU).

COVID Vaccination update: the exercise continues smoothly across the country. MOH Kenyan officials are conducting vaccine training in different parts of the country to expand the exercise to other facilities. Training will continue over the weekend as more people are expected to show up for vaccination after the priority list has been expanded to include those aged 58 and over.

Vaccines are safe and have been used to prevent disease for years. The benefits of vaccination far outweigh the risks, and there would be many more diseases and deaths without vaccines. Like any medicine, vaccines can cause mild side effects such as a mild fever or pain or redness at the injection site. Mild reactions will go away on their own within a few days. Serious or long-lasting side effects are extremely rare. Vaccines are continuously monitored for safety to identify rare adverse events.

Distributed by APO Group on behalf of the Ministry of Health, Kenya.Ministry of Health, Kenya
Download logo

Africanews offers its readers content from the APO Group as a service, but does not edit the articles it has published.

Comments are closed.